Published • loading... • Updated
Trudeau Institute researcher awarded NIH grants for new TB treatments
Summary by Adirondack Explorer
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Trudeau Institute researcher awarded NIH grants for new TB treatments
Trudeau Institute announced that Michaelle Chojnacki, Ph.D., has been awarded two competitive research grants from the National Institutes of Health (NIH) to develop groundbreaking therapies for tuberculosis (TB) which is the leading cause of death globally by a pathogen, with 1.3 million deaths annually. While therapeutic interventions for tuberculosis exist, they are lengthy, complex, accompanied by serious side effects and can result in patie…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
